Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | KLK7 | P49862 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30911235 | 1.00 | HTT (0.60) | HTTMEN1CYP1A2KMT2ACYP2C19 | |
| SCHEMBL69791 | 0.86 | HTT (0.69) | HTTMEN1CYP1A2KMT2ACYP2C19 | |
| SCHEMBL28035437 | 0.84 | KLK7 (0.52) | HTTKLK7ALDH1A1POLBHPGD | |
| SCHEMBL21981938 | 0.84 | HTT (0.67) | HTTMEN1CYP1A2KMT2ACYP2C19 | |
| Ethylene SCHEMBL22615238 | 0.82 | HTT (0.64) | HTTMEN1CYP1A2KMT2ACYP2C19 | |
| SCHEMBL9349735 | 0.81 | KLK7 (0.57) | HTTKLK7ALDH1A1POLBHPGD | |
| SCHEMBL19442049 | 0.81 | HTT (0.58) | HTTMEN1CYP1A2KMT2ACYP2C19 | |
| Propane SCHEMBL28412029 | 0.80 | HTT (0.68) | HTTMEN1CYP1A2KMT2ACYP2C19 | |
| SCHEMBL17274259 | 0.79 | TDP1 (0.52) | KLK7ALDH1A1POLBHPGDTSHR | |
| SCHEMBL669793 | 0.79 | HDAC4 (0.62) | ALDH1A1POLBKDM4EHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110206-A1 | PERFUME, PERFUME COMPOSITION, METHOD FOR PRODUCING PERFUME, AND COMPOUND | 三菱瓦斯化学株式会社 | 2025-05-30 | — | — | WO | claimed |
| CN-118084836-A | Method for co-producing 1, 3-propanediol and dimethyl furandicarboxylate by using carbonate and furan compounds as raw materials | 华东师范大学 | 2024-05-28 | — | — | CN | claimed |
| US-11987892-B2 | Metal cleaning compositions comprising furoate esters and uses therefor | NORTH AMERICAN PRODUCTS GROUP, LLC (US) | 2024-05-21 | — | — | US | claimed |
| CN-112638888-B | Oxidation process for the production of 5- (alkoxycarbonyl) furan-2-carboxylic Acid (ACFC) | 伊士曼化工公司 | 2024-04-02 | — | — | CN | claimed |
| EP-3740662-B1 | METAL CLEANING COMPOSITIONS COMPRISING FUROATE ESTERS AND USES THEREFOR | QMAXX PRODUCTS GROUP INC (US) | 2023-08-16 | — | — | EP | claimed |
| CN-111153876-B | Method for producing furandicarboxylic acid and derivative thereof from furfural | 华东师范大学 | 2023-07-28 | — | — | CN | claimed |
| CN-111655372-B | Catalysts containing furans and their use in hydrotreating and/or hydrocracking processes | IFP 新能源公司 | 2023-07-25 | — | — | CN | claimed |
| CN-111868364-B | Metal cleaning composition comprising furoate ester and use thereof | 北美产品集团有限责任公司 | 2022-10-14 | — | — | CN | claimed |
| US-11440895-B2 | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) | EASTMAN CHEMICAL COMPANY (US) | 2022-09-13 | — | — | US | claimed |
| CN-114315728-A | Imidazole ionic liquid and application thereof in alcoholysis polymerization of 2, 5-furandicarboxylic acid ester | 中国科学院大连化学物理研究所 | 2022-04-12 | — | — | CN | claimed |
| EP-2350090-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | Xenon Pharmaceuticals Inc. (CA) | 2011-08-03 | — | — | EP | claimed |
| EP-1725537-B1 | NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-07-13 | — | — | EP | claimed |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2010-06-03 | — | — | US | claimed |
| WO-2010045251-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS, INC. (CA) | 2010-04-22 | — | — | WO | claimed |
| US-20090137801-A1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-28 | — | — | US | claimed |
| EP-1758905-B1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINE, THE PRODUCTION THEREOF AND THE USE IN THE FORM OF A DDP-IV INHIBITOR | BOEHRINGER INGELHEIM INT (DE) | 2009-04-29 | — | — | EP | claimed |
| US-7501426-B2 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-10 | — | — | US | claimed |
| US-20050234108-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-20 | — | — | US | claimed |
| EP-0649880-B1 | Metallized azo-ether dyes for optical recording layers | EASTMAN KODAK CO (US) | 2000-01-12 | — | — | EP | claimed |
| EP-0649880-A1 | Metallized azo-ether dyes for optical recording layers | EASTMAN KODAK COMPANY (US) | 1995-04-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137801-A1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | DPP8, DPP4, DPP7 | HTT 3572/4885MEN1 4401/4885CYP1A2 592/4885 |
| US-20050234108-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | DPP8, DPP4, DPP7 | HTT 3422/4885MEN1 3845/4885CYP1A2 616/4885 |
| US-11440895-B2 | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) | MCCC2, ACSL5, ACACB | HTT 4744/4885MEN1 1429/4885CYP1A2 394/4885 |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | TRPV3, TRPV1, TRPC3 | HTT 241/4885MEN1 2591/4885CYP1A2 846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.